Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Jeff J Mitchell/Getty Images

British Prime Minister Boris Johnson, under review by the police watchdog over conflicts of interest allegations concerning American businesswoman Jennifer Arcuri when he was London mayor, told the BBC Sunday there's "no interest to declare."

A tweet previously embedded here has been deleted or was tweeted from an account that has been suspended or deleted.

Why it matters: Johnson could face a possible criminal investigation over the claims, first reported by the Sunday Times, as fresh allegations emerged Saturday night.

Catch up quick: The Sunday Times reported previously that Arcuri’s companies received 2 sponsorship grants from Johnson's promotional agency while he was mayor and a 3rd grant this year valued at £100,000 ($123,000) from a former ministerial colleague in the government’s Department for Digital, Culture and Sport.

  • Per the BBC, the office said in a letter to Johnson, "[I]t has been brought to my attention that you maintained a friendship with Ms Jennifer Arcuri and as a result of that friendship allowed Ms Arcuri to participate in trade missions and receive sponsorship monies in circumstances when she and her companies could not have expected otherwise to receive those benefits."

Fresh allegations: The Observer reported late Saturday that Arcuri loaned more than £700,000 ($860,000) to her tech firm just before it won a £100,000 government grant. "It is unclear where the money channelled to Hacker House, a start-up with hardly any income, came from," The Observer said. "This adds to the mystery swirling around the American businesswoman ... and raises further questions for the government."

  • The Sunday Times reported late Saturday that Arcuri told 4 friends that she had an affair with Johnson while he was mayor.
  • The news outlet said David Enrich, now the New York Times' finance editor, had been told of the alleged relationship by 2 of her friends when he was working for another paper and that this account was corroborated by other sources who had spoken to Arcuri.

Context: The Independent Office for Police Conduct is reviewing the report concerning Johnson's time as mayor from 2008 to 2016 because London's mayor is also the capital's police and crime commissioner, the BBC notes.

The big picture: Johnson has had a turbulent start to his premiership since being elected Conservative Party leader in July. He lost 6 votes in the Houses of Commons before suspending Parliament, which the Supreme Court ruled last Tuesday unlawful, prompting the legislature's return.

  • He's also lost the government's majority, and the Conservative Party expelled 21 lawmakers for voting to take control of the legislative agenda in an effort to stop him from forcing through a no-deal Brexit on Oct. 31.

Go deeper: The scramble to build barriers to Boris

Editor's note: This article has been updated with Johnson's comments.

Go deeper

Ben Geman, author of Generate
59 mins ago - Energy & Environment

Democrats' clean power outlook is very muddy

Illustration: Annelise Capossela/Axios

Here are two big questions as a key Democratic proposal to slash emissions from power generation flounders: how much its demise would sap climate protections, and what might replace it.

Catch up fast: New financial carrots and sticks for utilities to deploy zero-carbon power — the Clean Electricity Performance Program (CEPP) — look unlikely to stay in Democrats' big social spending and climate bill.

Colin Powell dies from COVID complications at 84

Photo: Paul Morigi/Getty Images for Capital Concerts

Colin Powell, the first Black U.S. secretary of state, died of complications from COVID-19, his family announced Monday. He was 84.

Driving the news: The Powell family said in a statement that he was fully vaccinated. "We want to thank the medical staff at Walter Reed National Medical Center for their caring treatment."

3 hours ago - Health

This arthritis drug cost $198 in 2008. Now it's more than $10,000

Illustration: Aïda Amer/Axios

In 2008, a box of 30 anti-inflammatory rectal suppositories that treats arthritis, called Indocin, had a price tag of $198. As of Oct. 1, the price of that same box was 52 times higher, totaling $10,350.

Why it matters: As federal lawmakers continue to waver on drug price reforms, Indocin is another example of how nothing prevents drug companies from hiking prices at will and selling them within a broken supply chain.